JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PCF
6351
High Income Securities Fund
PCF
$94.9M
| $1.65K | ﹤0.01% |
+244
| New | +$1.6K |
2024 Q1
0 quarters
|
|
|
CMRX
6352
DELISTED
Chimerix, Inc.
CMRX
| $1.63K | ﹤0.01% |
1,539
-201,004
| -99% | -$209K |
2013 Q2
43 quarters
|
|
|
LAR
6353
Lithium Argentina AG
LAR
$926M
| $1.62K | ﹤0.01% |
300
-1,815
| -86% | -$8.81K |
2023 Q4
1 quarter
|
|
6354
Kartoon Studios
TOON
$35.4M
| $1.59K | ﹤0.01% |
1,160
-1,074
| -48% | -$1.47K |
2021 Q2
11 quarters
|
|
|
CSCI
6355
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $1.59K | ﹤0.01% |
181
-30
| -14% | -$231 |
2022 Q4
5 quarters
|
|
|
OPRA
6356
CALL
Opera Ltd
OPRA
$1.57B
| $1.58K | ﹤0.01% |
+100
| New | +$1.26K |
2024 Q1
0 quarters
|
|
6357
First Trust Energy AlphaDEX Fund
FXN
$371M
| $1.55K | ﹤0.01% |
+83
| New | +$1.4K |
2024 Q1
0 quarters
|
|
6358
BTC Digital
BTCT
$20.4M
| $1.52K | ﹤0.01% |
+434
| New | +$1.7K |
2024 Q1
0 quarters
|
|
6359
Fidelity Enhanced Large Cap Value ETF
FELV
$3.44B
| $1.52K | ﹤0.01% |
52
-201
| -79% | -$5.54K |
2023 Q4
1 quarter
|
|
6360
Playboy Inc
PLBY
$123M
| $1.52K | ﹤0.01% |
1,444
-38,438
| -96% | -$41K |
2021 Q2
11 quarters
|
|
6361
First Trust Dow Jones Select MicroCap Index Fund
FDM
$263M
| $1.51K | ﹤0.01% |
24
| – | – |
2022 Q4
5 quarters
|
|
|
BLEUW
6362
DELISTED
bleuacacia ltd Warrants
BLEUW
| – | – |
0
| – | – |
2022 Q2
7 quarters
|
|
6363
ALPS O'Shares Global Internet Giants ETF
OGIG
$104M
| $1.46K | ﹤0.01% |
38
| – | – |
2022 Q3
6 quarters
|
|
6364
Microbot Medical
MBOT
$71.2M
| $1.45K | ﹤0.01% |
1,181
+11
| +0.9% | +$14 |
2023 Q3
2 quarters
|
|
6365
AllianzIM U.S. Equity Buffer10 Jul ETF
JULT
$57.8M
| $1.43K | ﹤0.01% |
40
-352
| -90% | -$12.2K |
2023 Q4
1 quarter
|
|
6366
Globus Maritime Ltd
GLBS
$72.1M
| $1.39K | ﹤0.01% |
635
-2,421
| -79% | -$5.51K |
2022 Q3
6 quarters
|
|
6367
Hydrofarm Holdings
HYFM
$4.82M
| $1.37K | ﹤0.01% |
127
-186
| -59% | -$1.7K |
2023 Q4
1 quarter
|
|
6368
Citi Trends
CTRN
$400M
| $1.36K | ﹤0.01% |
+50
| New | +$1.44K |
2024 Q1
0 quarters
|
|
6369
Research Frontiers
REFR
$25.4M
| $1.35K | ﹤0.01% |
1,042
| – | – |
2020 Q2
15 quarters
|
|
6370
Reaves Utility Income Fund
UTG
$3.25B
| $1.35K | ﹤0.01% |
50
| – | – |
2023 Q4
1 quarter
|
|
6371
Fortress Biotech
FBIO
$69.4M
| $1.34K | ﹤0.01% |
672
-623
| -48% | -$1.24K |
2019 Q3
18 quarters
|
|
|
NFJ
6372
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.4B
| $1.33K | ﹤0.01% |
104
-40,198
| -100% | -$498K |
2022 Q1
8 quarters
|
|
6373
BioVie
BIVI
$12.6M
| $1.29K | ﹤0.01% |
24
+2
| +9% | +$205 |
2023 Q2
3 quarters
|
|
6374
Motley Fool 100 Index ETF
TMFC
$2.15B
| $1.29K | ﹤0.01% |
+26
| New | +$1.23K |
2024 Q1
0 quarters
|
|
|
GGN
6375
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$822M
| $1.28K | ﹤0.01% |
+333
| New | +$1.25K |
2024 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.